Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Immunome, Inc. (IMNM) Institutional Ownership & Insider Trading

202 institutions reported holding Immunome, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 39 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IMNMImmunome, Inc.Follow IMNM — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
16 Nov, in 23 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

202 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +1.8%.

Increased+70New+28Decreased-56Closed-22

Largest moves, shares (millions)

T. Rowe Price Investment…+3.3MMetLife Investment…+0.8MBlackRock+0.6MJefferies Financial Group-1.2MT. Rowe Price Associates-1.1MMarshall Wace-1.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+2.9Sep 24-1.9Dec 24+23.5Mar 25+2.5Jun 25+12.0Sep 25+28.2Dec 25-3.1Mar 26+2.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26202118+1.8%70285622
Mar 26198117-2.8%73394326
Dec 25181120+30.9%76393318
Sep 2515191+15.4%54243314
Jun 2514279+3.2%50253524
Mar 2514177+44.3%68351415
Dec 2411953-3.6%36263127
Sep 2411552+6.5%38202616

Immunome, Inc. — questions

Who owns Immunome, Inc. stock?
202 institutions reported Immunome, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: T. Rowe Price Investment Management, Inc. (17.3%), FMR LLC (15.0%), BlackRock, Inc. (7.8%).
Are Immunome, Inc. insiders buying or selling?
39 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Immunome, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.